Improve cognitive impairment using mefenamic acid non-steroidal anti-inflammatory therapy: additional beneficial effect found in a controlled clinical trial for prostate cancer therapy

Inflammation is an essential component of prostate cancer (PCa), and mefenamic acid has been reported to decrease its biochemical progression. The current standard therapy for PCa is androgen deprivation therapy (ADT), which has side effects such as cognitive dysfunction, risk of Alzheimer’s disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transl Res
Main Authors: Melnikov, Valery, Tiburcio-Jimenez, Daniel, Mendoza-Hernandez, Martha A, Delgado-Enciso, Josuel, De-Leon-Zaragoza, Luis, Guzman-Esquivel, Jose, Rodriguez-Sanchez, Iram P, Martinez-Fierro, Margarita L, Lara-Esqueda, Agustin, Delgado-Enciso, Osiris G, Jacinto-Cortes, Ivan, Zaizar-Fregoso, Sergio A, Paz-Michel, Brenda A, Murillo-Zamora, Efren, Delgado-Enciso, Ivan, Galvan-Salazar, Hector R
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8205720/
https://ncbi.nlm.nih.gov/pubmed/34150033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados